Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Investigation Evaluating Peristeen® Performance Characteristics of Scintigraphic Measurements in Patients With Neurogenic Bowel Dysfunction

NCT05381610 is registered in ClinicalTrials.gov with Coloplast A/S as lead sponsor.

NCT NCT05381610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05381610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Investigation Evaluating Peristeen® Performance Characteristics of Scintigraphic Measurements in Patients With Neurogenic Bowel Dysfunction
Lead sponsor
Coloplast A/S
Phase
Not applicable
Overall status
Terminated
Start date
June 1, 2022
Completion date
February 13, 2024
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bowel